Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo

Background: Non-small-cell lung cancer (NSCLC) was known as the most malignant tumor. Paclitaxel (PTX) is the effective drug used for the treatment of NSCLC; however, it also exhibits severe side effects. Emodin could induce apoptosis of NSCLC cells and serve as a potential cancer therapeutic agent....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shuifang, Zhang, Zeying, Zhang, Jianli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489594/
https://www.ncbi.nlm.nih.gov/pubmed/31114158
http://dx.doi.org/10.2147/DDDT.S196319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489594/
https://www.ncbi.nlm.nih.gov/pubmed/31114158
http://dx.doi.org/10.2147/DDDT.S196319

Ejemplares similares